Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT07228364 · RECRUITING
Trial details
- NCT number
- NCT07228364
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-10
- Primary completion
- 2027-05-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.